Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8321)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2015 (publication date) through Feb 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ozturk O, Colak Y, Senates E, Yilmaz Y, Ulasoglu C, Doganay L, Ozkanli S, Oltulu YM, Coskunpinar E, Tuncer I. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(26): 8096-8102 [PMID: 26185381 DOI: 10.3748/wjg.v21.i26.8096] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i26/8096.htm |
| Number | Citing Articles |
| 1 |
Fangping Jia, Xiao Hu, Takefumi Kimura, Naoki Tanaka. Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. International Journal of Molecular Sciences 2021; 22(19): 10303 doi: 10.3390/ijms221910303
|
| 2 |
Cheng-Maw Ho, Shu-Li Ho, Yung-Ming Jeng, Yu-Sheng Lai, Ya-Hui Chen, Shao-Chun Lu, Hui-Ling Chen, Po-Yuan Chang, Rey-Heng Hu, Po-Huang Lee. Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease. Journal of Inflammation 2019; 16(1) doi: 10.1186/s12950-019-0211-5
|
| 3 |
Avinash Kumar, Rashmi Pathak, Henry A. Palfrey, Kirsten P. Stone, Thomas W. Gettys, Subramanyam N. Murthy. High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-019-0422-z
|
| 4 |
Ching-Chih Chang, Hui-Chun Huang, Shao-Jung Hsu, Chon-Kit Pun, Chiao-Lin Chuang, Ming-Chih Hou, Fa-Yauh Lee. Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats. Journal of the Chinese Medical Association 2024; 87(5): 463 doi: 10.1097/JCMA.0000000000001075
|
| 5 |
Thuy-Trang T. Vo, Gyeyeong Kong, Chaeyeong Kim, Uijin Juang, Suhwan Gwon, Woohyeong Jung, Huonggiang Nguyen, Seon-Hwan Kim, Jongsun Park. Exploring scavenger receptor class F member 2 and the importance of scavenger receptor family in prediagnostic diseases. Toxicological Research 2023; 39(3): 341 doi: 10.1007/s43188-023-00176-2
|
| 6 |
Qidang Duan, Huiling Si, Limin Tian, Na Zhang, Jumei Qiu, Jing Yu, Jing Liu, Qi Zhang. LOX-1 attenuates high glucose-induced autophagy via AMPK/HNF4α signaling in HLSECs. Heliyon 2022; 8(12): e12385 doi: 10.1016/j.heliyon.2022.e12385
|
| 7 |
Emma R. Dorris, David E. Phelan, John Russell, Madeline Murphy. Bone morphogenetic protein-3 is a negative regulator of transforming growth factor beta and fibrosis. Biochemical and Biophysical Research Communications 2024; 738: 150497 doi: 10.1016/j.bbrc.2024.150497
|
| 8 |
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
|
| 9 |
Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers, Ger Koek. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2018; 16(6): 837 doi: 10.1016/j.cgh.2017.08.024
|
| 10 |
Amir Tajbakhsh, Seyed Mohammad Gheibihayat, Ramezan Ali Taheri, Mahdi Fasihi-Ramandi, Abolfazl Nesaei Bajestani, Abolfazl Taheri. Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review. Molecular Biology Reports 2022; 49(6): 5133 doi: 10.1007/s11033-022-07224-4
|